These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

759 related items for PubMed ID: 26315051

  • 1. Dynamic antimüllerian hormone levels during controlled ovarian hyperstimulation predict in vitro fertilization response and pregnancy outcomes.
    Styer AK, Gaskins AJ, Brady PC, Sluss PM, Chavarro JE, Hauser RB, Toth TL.
    Fertil Steril; 2015 Nov; 104(5):1153-61.e1-7. PubMed ID: 26315051
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Antimüllerian hormone as a predictor of good-quality supernumerary blastocyst cryopreservation among women with levels <1 ng/mL versus 1-4 ng/mL.
    Kavoussi SK, Odenwald KC, Boehnlein LM, Summers-Colquitt RB, Pool TB, Swain JE, Jones JM, Lindstrom MJ, Lebovic DI.
    Fertil Steril; 2015 Sep; 104(3):633-6. PubMed ID: 26144573
    [Abstract] [Full Text] [Related]

  • 4. Can highly sensitive antimüllerian hormone testing predict failed response to ovarian stimulation?
    Burks HR, Ross L, Opper N, Paulson E, Stanczyk FZ, Chung K.
    Fertil Steril; 2015 Sep; 104(3):643-8. PubMed ID: 26158904
    [Abstract] [Full Text] [Related]

  • 5. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
    Nardo LG, Gelbaya TA, Wilkinson H, Roberts SA, Yates A, Pemberton P, Laing I.
    Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
    [Abstract] [Full Text] [Related]

  • 6. Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial.
    Nyboe Andersen A, Nelson SM, Fauser BC, García-Velasco JA, Klein BM, Arce JC, ESTHER-1 study group.
    Fertil Steril; 2017 Feb; 107(2):387-396.e4. PubMed ID: 27912901
    [Abstract] [Full Text] [Related]

  • 7. Antimüllerian hormone as a predictor of live birth following assisted reproduction: an analysis of 85,062 fresh and thawed cycles from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database for 2012-2013.
    Tal R, Seifer DB, Wantman E, Baker V, Tal O.
    Fertil Steril; 2018 Feb; 109(2):258-265. PubMed ID: 29331235
    [Abstract] [Full Text] [Related]

  • 8. The dynamic changes of anti-Mullerian hormone and inhibin B during controlled ovarian hyperstimulation in decreased ovarian reserve women and the effect on clinical outcome.
    Li Y, Nie M, Liu Y, Zhang W, Yang X.
    Gynecol Endocrinol; 2015 Jun; 31(6):450-3. PubMed ID: 25585549
    [Abstract] [Full Text] [Related]

  • 9. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.
    Hazout A, Bouchard P, Seifer DB, Aussage P, Junca AM, Cohen-Bacrie P.
    Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354
    [Abstract] [Full Text] [Related]

  • 10. Randomized, assessor-blind, antimüllerian hormone-stratified, dose-response trial in Japanese in vitro fertilization/intracytoplasmic sperm injection patients undergoing controlled ovarian stimulation with follitropin delta.
    Ishihara O, Klein BM, Arce JC, Japanese Follitropin Delta Phase 2 Trial Group.
    Fertil Steril; 2021 Jun; 115(6):1478-1486. PubMed ID: 33272623
    [Abstract] [Full Text] [Related]

  • 11. Anti-Müllerian hormone levels to predict oocyte maturity and embryo quality during controlled ovarian hyperstimulation.
    Melado Vidales L, Fernández-Nistal A, Martínez Fernández V, Verdú Merino V, Bruna Catalán I, Bajo Arenas JM.
    Minerva Ginecol; 2017 Jun; 69(3):225-232. PubMed ID: 27352270
    [Abstract] [Full Text] [Related]

  • 12. Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials.
    Nelson SM, Klein BM, Arce JC.
    Fertil Steril; 2015 Apr; 103(4):923-930.e1. PubMed ID: 25624196
    [Abstract] [Full Text] [Related]

  • 13. Follicular fluid anti-Müllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles.
    Lee JR, Kim SH, Kim SM, Jee BC, Ku SY, Suh CS, Choi YM, Kim JG, Moon SY.
    Fertil Steril; 2008 Apr; 89(4):860-7. PubMed ID: 18249372
    [Abstract] [Full Text] [Related]

  • 14. Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients.
    Arce JC, La Marca A, Mirner Klein B, Nyboe Andersen A, Fleming R.
    Fertil Steril; 2013 May; 99(6):1644-53. PubMed ID: 23394782
    [Abstract] [Full Text] [Related]

  • 15. 450 IU versus 600 IU gonadotropin for controlled ovarian stimulation in poor responders: a randomized controlled trial.
    Lefebvre J, Antaki R, Kadoch IJ, Dean NL, Sylvestre C, Bissonnette F, Benoit J, Ménard S, Lapensée L.
    Fertil Steril; 2015 Dec; 104(6):1419-25. PubMed ID: 26361207
    [Abstract] [Full Text] [Related]

  • 16. Anti-Müllerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization/intracytoplasmic sperm injection.
    Wunder DM, Guibourdenche J, Birkhäuser MH, Bersinger NA.
    Fertil Steril; 2008 Dec; 90(6):2203-10. PubMed ID: 18291376
    [Abstract] [Full Text] [Related]

  • 17. Is the type of gonadotropin-releasing hormone suppression protocol for ovarian hyperstimulation associated with ectopic pregnancy in fresh autologous cycles for in vitro fertilization?
    Londra L, Moreau C, Strobino D, Bhasin A, Zhao Y.
    Fertil Steril; 2016 Sep 01; 106(3):666-72. PubMed ID: 27320035
    [Abstract] [Full Text] [Related]

  • 18. A randomized, controlled, pilot trial on the effect of dehydroepiandrosterone on ovarian response markers, ovarian response, and in vitro fertilization outcomes in poor responders.
    Yeung TW, Chai J, Li RH, Lee VC, Ho PC, Ng EH.
    Fertil Steril; 2014 Jul 01; 102(1):108-115.e1. PubMed ID: 24796766
    [Abstract] [Full Text] [Related]

  • 19. Relationship Between Anti-Müllerian Hormone and In Vitro Fertilization-Embryo Transfer in Clinical Pregnancy.
    Sun XY, Lan YZ, Liu S, Long XP, Mao XG, Liu L.
    Front Endocrinol (Lausanne); 2020 Jul 01; 11():595448. PubMed ID: 33343511
    [Abstract] [Full Text] [Related]

  • 20. Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimüllerian hormone-stratified, dose-response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection.
    Arce JC, Andersen AN, Fernández-Sánchez M, Visnova H, Bosch E, García-Velasco JA, Barri P, de Sutter P, Klein BM, Fauser BC.
    Fertil Steril; 2014 Dec 01; 102(6):1633-40.e5. PubMed ID: 25256937
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.